Quick Answer
NEPHROS INC reported Total Revenue of $18.79 million for the year ending 2025.
- NEPHROS INC showed an increase of +32.7% in Total Revenue from 2024 to 2025.
- This data is from NEPHROS INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $859.0 thousand | Q3 2017: $916.0 thousand | Q1 2018: $985.0 thousand | Q2 2018: $1.37 million | Q3 2018: $1.72 million | Q1 2019: $1.77 million | Q2 2019: $2.31 million | Q3 2019: $3.10 million | Q1 2020: $2.53 million | Q2 2020: $1.58 million | Q3 2020: $2.12 million | Q1 2021: $2.74 million | Q2 2021: $2.27 million | Q3 2021: $2.58 million | Q1 2022: $2.16 million | Q2 2022: $2.85 million | Q3 2022: $2.41 million | Q1 2023: $3.70 million | Q2 2023: $3.55 million | Q3 2023: $3.74 million | Q1 2024: $3.52 million | Q2 2024: $3.25 million | Q3 2024: $3.52 million | Q1 2025: $4.88 million | Q2 2025: $4.42 million | Q3 2025: $4.76 million.
- Over the full 9 years of available data (2017 to 2025), NEPHROS INC's Total Revenue has grown by 393.3%.
- Historical annual values: Fiscal year 2025: $18.79 million | Fiscal year 2024: $14.16 million | Fiscal year 2023: $14.24 million | Fiscal year 2022: $9.98 million | Fiscal year 2021: $10.22 million | Fiscal year 2020: $8.56 million | Fiscal year 2019: $10.33 million | Fiscal year 2018: $5.69 million | Fiscal year 2017: $3.81 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: